- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02578927
Green Tea Attenuates Pressure Reduction Induced by a Session of Physical Exercise
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects of study: Double- blind study, randomized and placebo, conduced with fifteen both sexes hypertensive individuals, physically active and practitioners of exercises for at least 3 months prior to trials. All patients were users of anti- hypertensive medication except beta- blockers and maintained medication throughout study period. They were demanded not to be diabetic and women not menopaused. The research was approved by the Ethics Committee on Research with Human Beings of the Health Sciences Centre at the Federal University of Paraiba- CEP/ CCS, under the protocol 0120/13. Individuals were required to sign The Free and Clarified Consent Term (FCCT), according to resolution 196/96 of National Health Council.
Study Designs: subjects performed three experimental procedures, two practicing aerobic exercises and one without physical exercises. The sessions with exercises were conducted under previous administration of a green tea dosage or placebo (GT+Ex or PL+Ex), ingested 30 minutes before the start of exercises protocol. In the session without exercises (GT) they ingested green tea and remained sit during the same period destined to the exercises. Heart Rate Measurement were registered at rest (RHR) and in every ten minutes during physical exercise protocol. BP measurements were taken before (at rest), immediately after exercise and in every ten minutes during a recovery period of 60 minutes after the end of exercise protocol, or in the period they remained sit. Blood samples were collected prior and immediately after exercise or period without exercise for analysis of plasmatic concentration of anti and pro- oxidant agents (nitrite- NO and Malondialdehyde- MDA).
Instruments and Procedures:Physical Exercises: After the purposes of the research were clarified to the individuals, they were invited to proceed to the laboratory in order for exercise sessions performance. The groups were submitted to three sessions, two of those on treadmill aerobic exercise during 60 minutes. Furthermore, it was established that the individuals should practice exercises scoring between 11 and 14 in Borg and Noble's Subjective Perceived Exertion Scale. They were requested to hold the intensity of physical exercises from 60% to 85% of HRmax (maximum Heart Rate), monitored during sessions with a Polar frequency meter model RS800CX (Polar ElectroOy, Kempele, Finland).
Supplementation of Green Tea or Placebo: Green tea and placebo capsules were produced in a compounding laboratory. The investigators used 2g of green tea dried leaves and discovered an improvement in oxidative stress. The group with green tea consumption ingested capsules with 2g of concentrated powder, approximately 1960mg in polyphenols (636mg of epigallocatechin gallate) and 20mg of caffeine; placebo group consumed capsules containing 2g of cornstarch powder, all swallowed with water. Capsules were administered to patients after a skilled professional collected blood samples. Researchers conducted supplementation of substances after pre- exercise blood collection and sessions initiated only 30 minutes after the ingestion of capsules, which is the time required by the body to absorb nutrients.
Blood Pressure Measurement: Individuals had their BPs checked previously, immediately after the end of the exercise and during 60 minutes post- exercise. BP at rest was verified after the subjects remained sit for 10 minutes. By the end of the walking session, BP was checked with sitting subjects. During recovery, BP was verified in every 10 minutes during all 60 minutes of walking session. The protocol adopted was the one proposed by the Brazilian Society of Cardiology and the Brazilian Society of Hypertension.
Blood Collection Protocol: Performed prior and immediately after exercise. Ten milliliters (ml) of blood were collected from the antecubital vein, of which five ml were placed in test tubes containing EDTA and carefully homogenized by inversion. The other five ml were placed in tubes without any anticoagulant. Then they were centrifuged at 1500 rpm for 20 minutes. Plasma was isolated, placed in ependorf tubes and refrigerated in 20 ºC until analysis.
Evaluation of oxidative stress (MDA): Oxidizing activity was quantified through thiobarbituric acid reaction with the products from hydroperoxides decomposition. Therefore, 250 µl of sample was added to KCl and incubated in water bath maintained at 37° C for 60 minutes. Then mixture was precipitated with 35% AA perchloric and centrifuged at 14000 rpm and 4°C for 10 minutes. Supernatant was transferred to new ependorfs, adding 400 µl of 0.6% thiobarbituric acid and incubated at 95-100° C for 30 min. After cooling, material was read by spectrophotometer at a wavelength of 532nm.
Nitrite Dosage The method was based on the Griess reagent usage. Reagent was prepared utilizing equal parts of 5% phosphoric acid, 0.1% N-1-naphthalenediamine (NEED), 1% sulphanilamide, 5% in phosphoric acid and distilled water. To accomplish the test, 100 µl of 10% homogenate supernatant made with potassium phosphate buffer was added to 100µl Griess reagent. Regarding the white one, 100 µl reagent was added to 100 µl of buffer and series of dilutions were conducted to obtain standard curve (100, 50, 25 12.5, 6.25, 3.12, 1.56 µm) of nitrite. The entire test was executed in a 96 well- plate template with reader at an absorbance range of 560 nm.
Data Analysis Process: Initially, all data were tested concerned its normality and variability in standard error. Subsequently, one-way ANOVA tests were applied in order to compare basal conditions within three days of proceedings. Instat 3.0 software (GraphPAdInstat, San Diego, CA, USA) was utilized during analysis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hypertensive
- Physically active for at least 3 months
- Not diabetics individuals.
Exclusion Criteria:
- Modifying the therapeutic treatment during the study
- Use beta-blocker drugs, and calcium channel blockers
- Menopausal women.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: GT+Ex
Ingestion of one dose of 2 g of green tea (GT) ingested at 10 minutes after the period of rest.
After the Ingestion, the volunteers practice aerobic exercise (EX) in treadmill.
|
In this session the volunteers ingested capsules with 2g of powder green tea before exercise
|
|
Placebo Comparator: PL+Ex
Ingestion of one dose 2 g of placebo (PL) ingested at 10 minutes after the period of rest.
After the Ingestion, the volunteers practice aerobic exercise (EX) in treadmill.
|
In this session the volunteers ingested capsules with 2g of placebo before exercise
|
|
Active Comparator: Green Tea
Ingestion of one dose 2g of green tea (GT) at 10 minutes after the period of rest.
In this section the volunteers does not practice aerobic exercise.
|
In this investigation the volunteers ingested capsules with 2g of powder green tea before the rest similar to the exercise time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: Change from baseline Bood Pressure at 60 minutes post exercise in the same experimental session
|
The sessions of exercise were released with interval of 30 days between them, thus each volunteer devoted an average 40 days to the study.
|
Change from baseline Bood Pressure at 60 minutes post exercise in the same experimental session
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Manoel Miranda Neto, graduation, Federal University of Paraíba
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUParaíba
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on GT+Ex
-
Swarthmore CollegeUniversity of PennsylvaniaUnknownDepression | AnxietyUnited States
-
Children's Mercy Hospital Kansas CityCompletedGastroesophageal Reflux | Family Satisfaction | Feeding DisorderUnited States
-
Gain Therapeutics, Inc.RecruitingParkinson DiseaseAustralia
-
University of CalgaryCompletedSpinal Cord InjuriesCanada
-
Maharishi Markendeswar University (Deemed to be...Not yet recruiting
-
Ekso BionicsTerminatedSpinal Cord InjuriesUnited States
-
Stryker Trauma and ExtremitiesActive, not recruitingFemoral FractureUnited States
-
Vrije Universiteit BrusselTerminated
-
University of Colorado, DenverCompletedOverweight and ObesityUnited States